Berberine promotes expression of AQP4 in astrocytes by regulating production of miR-383-5p in HepG2 cell-derived exosomes under insulin resistance.
10.19540/j.cnki.cjcmm.20240925.301
- Author:
Xue-Ling LIN
1
;
Ying LI
1
;
Meng-Qing GUO
1
;
Yan-Jun ZHANG
2
;
Qing-Sheng YIN
1
;
Peng-Wei ZHUANG
2
Author Information
1. National Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China.
2. National Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin 300193, China National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion Tianjin 300193, China.
- Publication Type:Journal Article
- Keywords:
HA1800 cells;
HepG2 cells;
aquaporin 4(AQP4);
berberine;
exosomes;
miR-383-5p
- MeSH:
Humans;
MicroRNAs/metabolism*;
Berberine/pharmacology*;
Hep G2 Cells;
Exosomes/genetics*;
Aquaporin 4/metabolism*;
Insulin Resistance;
Astrocytes/drug effects*
- From:
China Journal of Chinese Materia Medica
2025;50(3):768-775
- CountryChina
- Language:Chinese
-
Abstract:
This study aims to explore the role and mechanism of berberine in promoting the expression of aquaporin 4(AQP4) in astrocytes by regulating the expression of miR-383-5p in HepG2 cell-derived exosomes under insulin resistance(IR). The IR-HepG2 cell model was established with 1×10~(-6) mol·L~(-1) insulin. With metformin as the positive control, the safe concentrations of berberine and metformin were screened by cell counting kit-8(CCK-8) and lactate dehydrogenase(LDH) leakage assays, and the effect of berberine on the IR of HepG2 cells was evaluated by glucose consumption. NanoSight was used to measure the particle size and concentration of exosomes secreted by HepG2 cells in each group. HepG2 cell-derived exosomes in each group were incubated with astrocytes for 24 h, and the protein and mRNA levels of AQP4 in HA1800 cells were determined by Western blot and qRT-PCR, respectively. qRT-PCR was performed to determine the expression of miR-383-5p in HepG2 cell-derived exosomes and HA1800 cells after co-incubation. Western blotting was employed to determine the expression levels of miRNAs and proteins associated with exosome production and release in HepG2 cells. The results showed that 10 μmol·L~(-1) berberine and 1 mmol·L~(-1) metformin significantly alleviated the IR of HepG2 cells and reduced the concentration of exosomes in HepG2 cells. The exosomes of HepG2 cells treated with berberine and metformin significantly up-regulated the protein and mRNA levels of AQP4 in HA1800 cells. The mRNA level of miR-383-5p in HepG2 cell exosomes and HA1800 cells co-incubated with berberine and metformin decreased significantly. The intervention with berberine and metformin significantly down-regulated the expression of proteins associated with the production of miRNAs(Dicer, Drosha) as well as the production(Alix, Vps4A) and release(Rab35, VAMP3) of exosomes in IR-HepG2 cells. In conclusion, berberine can promote the expression of AQP4 in astrocytes by inhibiting the production and release of miR-383-5p in HepG2-derived exosomes under IR.
